RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: small cell carcinoma
Accession: DOID:0050685
browse the term
Definition: A carcinoma that is an undifferentiated neoplasm composed of primitive-appearing cells. (DO)
Synonyms: exact_synonym: SCCL; SCLC; SCLC1; oat cell carcinoma; oat cell carcinomas; small cell carcinomas
narrow_synonym: Salivary Gland Small Cell Carcinoma; small cell carcinoma, intermediate cell
xref: EFO:0008524 ; EFO:1000519 ; ICDO:8041/3; MESH:D018288 ; MIM:182280 ; MONDO:0000402 ; NCI:C4099
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
Birc5
baculoviral IAP repeat-containing 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15981204
NCBI chr10:103,567,369...103,580,069
Ensembl chr10:103,073,408...103,081,380
G
Chi3l1
chitinase 3 like 1
severity
ISO
protein:increased secretion:serum (human)
RGD
PMID:15541818
RGD:4892640
NCBI chr13:48,193,839...48,201,822
Ensembl chr13:45,641,802...45,649,787
G
Chrm3
cholinergic receptor, muscarinic 3
ISO
RGD
PMID:20150622
RGD:5133439
NCBI chr17:64,696,549...65,158,622
Ensembl chr17:60,005,202...60,467,278
G
Ikzf3
IKAROS family zinc finger 3
ISO
protein:increased expression:lung (human)
RGD
PMID:24823637
RGD:151347636
NCBI chr10:83,956,850...84,049,861
Ensembl chr10:83,465,745...83,553,591
G
Il6
interleukin 6
disease_progression
ISO
protein:increased expression:serum
RGD
PMID:20592377
RGD:4143263
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,213,394...5,219,178
G
Mtor
mechanistic target of rapamycin kinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20946520
NCBI chr 5:164,167,985...164,277,438
Ensembl chr 5:158,884,804...158,994,311
G
Nppa
natriuretic peptide A
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:18717826
NCBI chr 5:163,712,184...163,713,493
Ensembl chr 5:158,429,042...158,430,351
G
Nqo1
NAD(P)H quinone dehydrogenase 1
susceptibility
ISO
DNA:SNP:exon:609C>T (human)
RGD
PMID:11679176
RGD:5135003
NCBI chr19:52,205,374...52,220,267
Ensembl chr19:35,295,573...35,310,557
G
Pycard
PYD and CARD domain containing
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16778195
NCBI chr 1:192,032,124...192,033,419
Ensembl chr 1:182,601,174...182,602,955
G
Rassf1
Ras association domain family member 1
ISO
RGD
PMID:12222680
RGD:2291977
NCBI chr 8:117,103,665...117,114,805
Ensembl chr 8:108,225,023...108,236,164
G
Rb1
RB transcriptional corepressor 1
ISO
CTD Direct Evidence: marker/mechanism
OMIM CTD
NCBI chr15:54,780,858...54,911,989
Ensembl chr15:48,371,296...48,502,302
G
Smarca4
SWI/SNF related BAF chromatin remodeling complex subunit ATPase 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24658001 PMID:24658002 PMID:24658004 PMID:26343384
NCBI chr 8:28,438,370...28,535,071
Ensembl chr 8:20,167,717...20,258,975
G
Tert
telomerase reverse transcriptase
susceptibility
ISO
DNA:SNP: :rs2736098(human)
RGD
PMID:24761905
RGD:150530628
NCBI chr 1:31,465,766...31,488,650
Ensembl chr 1:29,637,506...29,659,561
G
Tnf
tumor necrosis factor
severity
ISO
protein:decreased secretion:whole blood
RGD
PMID:8624296
RGD:4142840
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,622,011...3,624,629
G
Tnfsf10
TNF superfamily member 10
ISO
RGD
PMID:16313792
RGD:2312747
NCBI chr 2:112,136,550...112,155,903
Ensembl chr 2:110,207,916...110,225,135
G
Tp53
tumor protein p53
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17290066
NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,300,048...54,311,524
G
Ugt1a1
UDP glucuronosyltransferase family 1 member A1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20946520
NCBI chr 9:96,249,143...96,256,264
Ensembl chr 9:88,713,184...88,808,465
G
Wif1
Wnt inhibitory factor 1
ISO
protein:decreased expression:lung
RGD
PMID:14517837
RGD:727214
NCBI chr 7:58,433,326...58,503,853
Ensembl chr 7:56,548,053...56,618,360
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
Krt14
keratin 14
IEP
protein:increased expression:esophagus
RGD
PMID:16140947
RGD:1600174
NCBI chr10:85,638,182...85,642,450
Ensembl chr10:85,066,802...85,171,799
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
Acvr1b
activin A receptor type 1B
ISO
RGD
PMID:33880365
RGD:151665493
NCBI chr 7:134,164,987...134,208,389
Ensembl chr 7:132,286,275...132,329,673
G
Adcy1
adenylate cyclase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22941189
NCBI chr14:86,125,119...86,234,459
Ensembl chr14:81,911,099...82,028,969
G
Apoa1
apolipoprotein A1
treatment
ISO
RGD
PMID:26996551
RGD:11561502
NCBI chr 8:55,423,945...55,425,729
Ensembl chr 8:46,527,144...46,529,035
G
Apoc3
apolipoprotein C3
treatment
ISO
RGD
PMID:26996551
RGD:11561502
NCBI chr 8:55,428,172...55,430,352
Ensembl chr 8:46,531,478...46,533,583
G
Ascl1
achaete-scute family bHLH transcription factor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26253517
NCBI chr 7:23,790,642...23,793,509
Ensembl chr 7:21,903,126...21,905,993
G
Atm
ATM serine/threonine kinase
susceptibility
ISO
DNA:SNP:intron:(rs227060) (human)
RGD
PMID:28642860
RGD:150383339
NCBI chr 8:62,724,939...62,829,040
Ensembl chr 8:53,831,093...53,932,437
G
Atrx
ATRX, chromatin remodeler
disease_progression
ISO
RGD
PMID:31374064 PMID:29748005
RGD:127285382 , RGD:127285383
NCBI chr X:74,916,548...75,062,880
Ensembl chr X:70,850,981...70,997,330
G
Avp
arginine vasopressin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:2832203
NCBI chr 3:138,246,544...138,248,522
Ensembl chr 3:117,793,457...117,795,425
G
Axin2
axin 2
disease_progression
ISO
DNA:SNP::1386 C>T(human)
RGD
PMID:30346805
RGD:151356655
NCBI chr10:94,393,379...94,426,579
Ensembl chr10:93,899,245...93,926,231
G
B2m
beta-2 microglobulin
ISO
ClinVar Annotator: match by term: Small cell lung cancer | ClinVar Annotator: match by term: Small cell lung carcinoma
ClinVar
PMID:26619011
NCBI chr 3:129,549,236...129,555,354
Ensembl chr 3:109,095,729...109,101,766
G
Bcl2
BCL2, apoptosis regulator
susceptibility
ISO
DNA:SNP: :rs2279115(human)
RGD
PMID:26311051
RGD:13673911
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Bclaf1
BCL2-associated transcription factor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22941189
NCBI chr 1:16,904,572...16,937,106
Ensembl chr 1:15,070,894...15,148,832
G
Ccnd1
cyclin D1
disease_progression
ISO
DNA:snp:exon:c.870G>A (human)
RGD
PMID:29739297
RGD:13673912
NCBI chr 1:209,518,288...209,527,986
Ensembl chr 1:200,089,002...200,098,602
G
Cdkn1b
cyclin-dependent kinase inhibitor 1B
ISO
protein:increased expression:lung
RGD
PMID:9500468
RGD:13673920
NCBI chr 4:169,491,273...169,496,500
Ensembl chr 4:167,760,181...167,764,982
G
Cdyl
chromodomain Y-like
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22941189
NCBI chr17:29,188,697...29,409,805
Ensembl chr17:28,982,037...29,204,313
G
Chrna3
cholinergic receptor nicotinic alpha 3 subunit
susceptibility
ISO
mRNA:increased expression:lung DNA:SNP:cds:rs8040868(human)
RGD
PMID:20124469 PMID:22280835
RGD:150527851 , RGD:151347453
NCBI chr 8:64,297,755...64,311,251
Ensembl chr 8:55,401,702...55,415,165
G
Chrna5
cholinergic receptor nicotinic alpha 5 subunit
ISO
mRNA:increased expression:lung
RGD
PMID:20124469
RGD:150527851
NCBI chr 8:64,265,879...64,294,233
Ensembl chr 8:55,369,794...55,398,146
G
Chrna9
cholinergic receptor nicotinic alpha 9 subunit
susceptibility
ISO
DNA:SNPs:multiples:
RGD
PMID:22280835
RGD:151347453
NCBI chr14:42,588,948...42,595,669
Ensembl chr14:42,235,226...42,242,192
G
Chrnb4
cholinergic receptor nicotinic beta 4 subunit
ISO
mRNA:increased expression:lung
RGD
PMID:20124469
RGD:150527851
NCBI chr 8:64,312,644...64,333,319
Ensembl chr 8:55,418,313...55,437,027
G
Ckb
creatine kinase B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:2828370
NCBI chr 6:136,550,583...136,553,464
Ensembl chr 6:130,729,423...130,732,315
G
Cntnap2
contactin associated protein 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22941189
NCBI chr 4:75,109,358...77,366,258
Ensembl chr 4:74,109,472...76,362,027
G
Col22a1
collagen type XXII alpha 1 chain
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22941189
NCBI chr 7:103,730,939...103,968,452
Ensembl chr 7:103,731,037...103,968,462
G
Col4a2
collagen type IV alpha 2 chain
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22941189
NCBI chr16:84,749,672...84,885,520
Ensembl chr16:78,047,602...78,183,839
G
Crebbp
CREB binding protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22941188
NCBI chr10:11,842,307...11,968,266
Ensembl chr10:11,335,953...11,461,888
G
Csf1r
colony stimulating factor 1 receptor
exacerbates
ISO
protein:increased expression:lung (human)
RGD
PMID:1390197
RGD:150524305
NCBI chr18:56,834,152...56,860,804
Ensembl chr18:54,546,659...54,590,415
G
Csf3
colony stimulating factor 3
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:9093707
NCBI chr10:84,157,485...84,159,860
Ensembl chr10:83,661,207...83,663,603
G
Cyp24a1
cytochrome P450, family 24, subfamily a, polypeptide 1
susceptibility
ISO
DNA:SNP:CDS: (rs6068816) (human)
RGD
PMID:31264381
RGD:151665340
NCBI chr 3:179,694,647...179,709,083
Ensembl chr 3:159,275,947...159,290,383
G
Dip2c
disco-interacting protein 2 homolog C
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22941189
NCBI chr17:60,647,346...61,032,467
Ensembl chr17:60,649,065...61,032,305
G
Dll4
delta like canonical Notch ligand 4
treatment
IEP
RGD
PMID:33628824
RGD:155663482
NCBI chr 3:126,770,945...126,780,769
Ensembl chr 3:106,316,986...106,326,931
G
Dnmt3b
DNA methyltransferase 3 beta
susceptibility
ISO
DNA:SNPs:promoter:-283T >C,-579G>T(human)
RGD
PMID:15528220
RGD:9589086
NCBI chr 3:162,590,777...162,629,313
Ensembl chr 3:142,130,592...142,169,124
G
E2f1
E2F transcription factor 1
disease_progression treatment
ISO
mRNA, protein:increased expression:lung
RGD
PMID:24755270 PMID:11313916 PMID:23792570
RGD:13464335 , RGD:13464344 , RGD:13464337
NCBI chr 3:163,524,739...163,535,563
Ensembl chr 3:143,049,478...143,075,361
G
Eef2
eukaryotic translation elongation factor 2
ISO
protein:increased expression:lung (human)
RGD
PMID:24589652
RGD:153297816
NCBI chr 7:9,183,836...9,196,255
Ensembl chr 7:8,533,116...8,559,183
G
Egfr
epidermal growth factor receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20837450
NCBI chr14:95,378,626...95,551,358
Ensembl chr14:91,177,067...91,344,382
G
Elavl2
ELAV like RNA binding protein 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22941189
NCBI chr 5:105,960,872...106,086,463
Ensembl chr 5:105,960,875...106,109,097
G
Ep300
E1A binding protein p300
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22941188
NCBI chr 7:114,987,857...115,058,652
Ensembl chr 7:113,106,247...113,136,088 Ensembl chr 7:113,106,247...113,136,088
G
Epha7
Eph receptor A7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22941188
NCBI chr 5:47,771,776...47,925,189
Ensembl chr 5:42,975,405...43,127,112
G
Fat1
FAT atypical cadherin 1
ISO
DNA:mutations:multiple (human)
RGD
PMID:31199602
RGD:150429733
NCBI chr16:53,909,759...54,029,175
Ensembl chr16:47,177,248...47,296,107
G
Fgfr1
Fibroblast growth factor receptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22941188
NCBI chr16:73,194,631...73,249,855
Ensembl chr16:66,494,042...66,547,350
G
Foxa1
forkhead box A1
disease_progression
ISO
RGD
PMID:22383183
RGD:151665760
NCBI chr 6:80,838,380...80,871,195
Ensembl chr 6:75,103,503...75,136,188
G
Grik3
glutamate ionotropic receptor kainate type subunit 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22941189
NCBI chr 5:143,052,442...143,268,873
Ensembl chr 5:137,767,865...137,984,307
G
Grm8
glutamate metabotropic receptor 8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22941189
NCBI chr 4:56,771,247...57,696,951
Ensembl chr 4:55,805,955...56,730,831
G
Grp
gastrin releasing peptide
disease_progression
ISO
protein:increased expression:serum (human)
RGD
PMID:30146822
RGD:401700396
NCBI chr18:61,658,655...61,672,037
Ensembl chr18:59,388,274...59,402,061
G
Id2
inhibitor of DNA binding 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23582323
NCBI chr 6:47,469,162...47,470,995
Ensembl chr 6:41,728,946...41,744,400
G
Insm1
INSM transcriptional repressor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23582323
NCBI chr 3:154,093,310...154,096,243
Ensembl chr 3:133,639,580...133,643,003
G
Itgb1
integrin subunit beta 1
disease_progression treatment
ISO
RGD
PMID:21063403 PMID:12168902
RGD:13792831 , RGD:13792832
NCBI chr19:73,602,277...73,650,271
Ensembl chr19:56,705,171...56,753,195
G
Kdm6a
lysine demethylase 6A
ISO
DNA:mutations:multiple: (human)
RGD
PMID:31199602
RGD:150429733
NCBI chr X:6,920,374...7,060,027
Ensembl chr X:4,337,750...4,477,062
G
Khsrp
KH-type splicing regulatory protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22941189
NCBI chr 9:1,949,557...1,959,400
Ensembl chr 9:1,862,899...1,872,451
G
Kif21a
kinesin family member 21A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22941189
NCBI chr 7:123,942,079...124,058,594
Ensembl chr 7:122,062,537...122,178,999
G
Kit
KIT proto-oncogene receptor tyrosine kinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15499612
NCBI chr14:32,901,615...32,978,895
Ensembl chr14:32,548,877...32,624,652
G
Kmt2a
lysine methyltransferase 2A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22941188
NCBI chr 8:54,013,547...54,089,219
Ensembl chr 8:45,118,814...45,193,181
G
Kmt2d
lysine methyltransferase 2D
disease_progression
ISO
DNA:missense mutations, insertion/deletion:plasma
RGD
PMID:28007623 PMID:29748005 PMID:27873319 PMID:29627316
RGD:150523766 , RGD:127285383 , RGD:150523768 , RGD:150523767
NCBI chr 7:131,859,696...131,901,032
Ensembl chr 7:129,962,887...130,020,325
G
Lama3
laminin subunit alpha 3
ISO
DNA:hyper-methylation:promoter:
RGD
PMID:12855645
RGD:13793369
NCBI chr18:3,797,898...4,033,021
Ensembl chr18:3,523,133...3,751,353
G
Lamb3
laminin subunit beta 3
ISO
DNA:hyper-methylation:promoter:
RGD
PMID:12855645
RGD:13793369
NCBI chr13:107,362,514...107,404,081
Ensembl chr13:104,833,873...104,875,405
G
Lamc2
laminin subunit gamma 2
ISO
DNA:hyper-methylation:promoter:
RGD
PMID:12855645
RGD:13793369
NCBI chr13:67,835,199...67,894,694
Ensembl chr13:65,284,664...65,344,200
G
Lyrm9
LYR motif containing 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22941189
NCBI chr10:64,223,732...64,237,791
Ensembl chr10:63,725,743...63,739,772
G
Max
MYC associated factor X
ISO
DNA:loss of heterozygosity:lung
RGD
PMID:24362264
RGD:13793386
NCBI chr 6:101,369,989...101,395,333
Ensembl chr 6:95,636,858...95,662,137
G
Mthfr
methylenetetrahydrofolate reductase
severity
ISO
protein:missense mutation:cds:p.A222V (human)
RGD
PMID:17533396
RGD:4891158
NCBI chr 5:163,748,346...163,768,141
Ensembl chr 5:158,465,296...158,483,797
G
Mtor
mechanistic target of rapamycin kinase
disease_progression
ISO
DNA:SNP: :rs2536(human)
RGD
PMID:28280736
RGD:13825123
NCBI chr 5:164,167,985...164,277,438
Ensembl chr 5:158,884,804...158,994,311
G
Myc
MYC proto-oncogene, bHLH transcription factor
disease_progression
ISO
RGD
PMID:28089889
RGD:13793389
NCBI chr 7:95,483,105...95,488,031
Ensembl chr 7:93,593,705...93,598,630
G
Mycl
MYCL proto-oncogene, bHLH transcription factor
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:22941189
NCBI chr 5:135,274,713...135,281,584
Ensembl chr 5:135,274,748...135,281,582
G
Ndrg1
N-myc downstream regulated 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15341671
NCBI chr 7:100,573,526...100,614,902
Ensembl chr 7:98,684,487...98,725,880
G
Notch1
notch receptor 1
treatment
IEP
RGD
PMID:33628824
RGD:155663482
NCBI chr 3:29,676,040...29,721,613
Ensembl chr 3:9,278,086...9,323,531
G
Pbrm1
polybromo 1
disease_progression
ISO
RGD
PMID:29748005
RGD:127285383
NCBI chr16:6,219,933...6,319,336
Ensembl chr16:6,213,300...6,311,780
G
Pik3ca
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
ISO
ClinVar Annotator: match by term: Small cell lung carcinoma
ClinVar
PMID:15016963 PMID:15254419 PMID:15520168 PMID:15608678 PMID:15647370 PMID:15805248 PMID:15930273 PMID:16906227 PMID:16930767 PMID:17673550 PMID:18676830 PMID:18725974 PMID:19029981 PMID:19223544 PMID:19366826 PMID:19513541 PMID:19903786 PMID:20453058 PMID:20619739 PMID:21078999 PMID:21430269 PMID:21558396 PMID:22162582 PMID:22162589 PMID:22209294 PMID:22271473 PMID:22357840 PMID:22658544 PMID:22729223 PMID:22729224 PMID:23066039 PMID:23408298 PMID:23888070 PMID:23946963 PMID:24033266 PMID:24265155 PMID:24559322 PMID:25157968 PMID:25599672 PMID:25741868 PMID:25880439 PMID:26619011 PMID:26627007 PMID:26637981 PMID:26851524 PMID:27631024 PMID:28151489 PMID:28425981 PMID:29661094 PMID:30376034 PMID:30543347 PMID:31536475 PMID:31775759 PMID:32778138 PMID:34496175 More...
NCBI chr 2:117,103,643...117,177,411
Ensembl chr 2:115,174,984...115,249,032
G
Pik3r1
phosphoinositide-3-kinase regulatory subunit 1
disease_progression
ISO
DNA:SNPs: :rs3756668,rs12755(human)
RGD
PMID:28280736
RGD:13825123
NCBI chr 2:34,612,946...34,697,660
Ensembl chr 2:32,882,032...32,963,631
G
Plscr4
phospholipid scramblase 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22941189
NCBI chr 8:101,867,057...101,905,827
Ensembl chr 8:92,987,381...93,026,049
G
Pten
phosphatase and tensin homolog
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22941188
NCBI chr 1:240,043,707...240,110,330
Ensembl chr 1:230,630,338...230,696,838
G
Ptk2
protein tyrosine kinase 2
disease_progression
ISO
DNA:CNV::
RGD
PMID:21800286 PMID:20802517
RGD:13825133 , RGD:13825141
NCBI chr 7:107,015,730...107,220,865
Ensembl chr 7:105,126,728...105,331,783
G
Rad52
RAD52 homolog, DNA repair protein
susceptibility treatment
ISO
DNA:SNP:3'utr: (rs7963551) (human) DNA:SNP: (rs10774474)(human)
RGD
PMID:26629180 PMID:27531263
RGD:151660337 , RGD:151660339
NCBI chr 4:154,778,320...154,802,002
Ensembl chr 4:153,106,062...153,128,207
G
Rarb
retinoic acid receptor, beta
ISO
DNA:methylation: :
RGD
PMID:29851970
RGD:13825142
NCBI chr15:10,837,252...11,482,037
Ensembl chr15:8,406,492...9,051,288
G
Rassf8
Ras association domain family member 8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22941189
NCBI chr 4:178,716,110...178,798,042
Ensembl chr 4:178,719,992...178,796,690
G
Rb1
RB transcriptional corepressor 1
ISO
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Small cell lung carcinoma
CTD ClinVar
PMID:2594029 PMID:22941188 PMID:22941189 PMID:25741868
NCBI chr15:54,780,858...54,911,989
Ensembl chr15:48,371,296...48,502,302
G
Rictor
RPTOR independent companion of MTOR, complex 2
severity
ISO
associated with Neoplasm Metastasis; protein:increased expression:lung, lymph node (human) DNA:CNV, amplification:exon (human)
RGD
PMID:31454632 PMID:27863413
RGD:152995447 , RGD:152995517
NCBI chr 2:57,539,279...57,631,291
Ensembl chr 2:55,811,322...55,901,426
G
Rims2
regulating synaptic membrane exocytosis 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22941189
NCBI chr 7:72,133,004...72,644,059
Ensembl chr 7:70,243,872...70,757,491
G
Runx1t1
RUNX1 partner transcriptional co-repressor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22941189
NCBI chr 5:31,984,946...32,136,878
Ensembl chr 5:27,187,551...27,335,592
G
Satb2
SATB homeobox 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22941189
NCBI chr 9:65,842,351...66,028,569
Ensembl chr 9:58,350,246...58,530,707
G
Skp2
S-phase kinase associated protein 2
ISO
mRNA:increased expression:lung:
RGD
PMID:12107105
RGD:13825152
NCBI chr 2:59,888,406...59,916,471
Ensembl chr 2:58,161,229...58,189,338
G
Slit2
slit guidance ligand 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22941188
NCBI chr14:66,829,661...67,168,517
Ensembl chr14:62,617,067...62,955,948
G
Smarca4
SWI/SNF related BAF chromatin remodeling complex subunit ATPase 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26343384
NCBI chr 8:28,438,370...28,535,071
Ensembl chr 8:20,167,717...20,258,975
G
Sox2
SRY-box transcription factor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22941189
NCBI chr 2:119,465,131...119,467,542
Ensembl chr 2:117,536,929...117,539,338
G
Tmem132d
transmembrane protein 132D
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22941189
NCBI chr12:33,905,971...34,553,267
Ensembl chr12:28,270,712...28,915,374
G
Tp53
tumor protein p53
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22941188 PMID:22941189
NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,300,048...54,311,524
G
Tp73
tumor protein p73
ISO
DNA:mutations:multiple: (human)
RGD
PMID:26168399
RGD:151347582
NCBI chr 5:169,903,801...169,988,075
Ensembl chr 5:164,621,377...164,681,128
G
Ttr
transthyretin
ISO
protein:increased expression:lung (human)
RGD
PMID:26943652
RGD:151665207
NCBI chr18:12,216,684...12,225,972
Ensembl chr18:11,943,789...11,951,008
G
Ubxn11
UBX domain protein 11
ISO
ClinVar Annotator: match by term: Small cell lung cancer | ClinVar Annotator: match by term: Small cell lung carcinoma
ClinVar
NCBI chr 5:151,613,411...151,637,274
Ensembl chr 5:146,329,842...146,353,526
G
Xpo5
exportin 5
severity
ISO
DNA:snp, haplotype:3' utr:c.*659A>C (rs11077) (human)
RGD
PMID:24648983
RGD:11041738
NCBI chr 9:22,237,760...22,275,745
Ensembl chr 9:14,740,182...14,778,171
G
Zdbf2
zinc finger, DBF-type containing 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22941189
NCBI chr 9:72,203,598...72,242,287
Ensembl chr 9:64,709,880...64,744,265
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
Brca2
BRCA2, DNA repair associated
ISO
ClinVar Annotator: match by term: Metastatic Prostate Small Cell Carcinoma
ClinVar
PMID:10550133 PMID:10660329 PMID:11597388 PMID:11802209 PMID:15024741 PMID:15689453 PMID:18393245 PMID:20104584 PMID:21952622 PMID:22009639 PMID:22144684 PMID:22535016 PMID:22666503 PMID:22798144 PMID:24033266 PMID:25525159 PMID:25741868 PMID:26439132 PMID:26467025 PMID:27257965 PMID:27433846 PMID:27836010 PMID:28039656 PMID:28324225 PMID:28492532 PMID:28724667 PMID:28993434 PMID:29084914 PMID:29176636 PMID:29339979 PMID:29446198 PMID:30078507 PMID:30093976 PMID:30274973 PMID:30287823 PMID:30322717 PMID:30702160 PMID:30720243 PMID:30787465 PMID:30875412 PMID:31214711 PMID:31263054 PMID:31447099 PMID:31742824 PMID:31825140 PMID:32295079 PMID:32318955 PMID:32341426 PMID:32467295 PMID:32710294 PMID:32853339 PMID:33471991 PMID:33608381 PMID:33918338 PMID:36988593 More...
NCBI chr12:4,895,092...4,939,340
Ensembl chr12:59,819...100,567
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all